Search Results

Navigating Challenges and Advances in Pediatric Psoriasis and Atopic Dermatitis Treatment.

• Authors : Lovell, Katie K.; Strowd, Lindsay C.; Feldman, Steven R.

Subjects: ATOPIC dermatitis treatment; PSORIASIS treatment; SERIAL publications

• Source: Children; Dec2023, Vol. 10 Issue 12, p1909, 4p

Record details

Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.

• Authors : Wu, Jashin J.¹ ; Feldman, Steven R.²; Rastogi, Shipra³

• Source: Journal of Dermatological Treatment. Dec2018, Vol. 29 Issue 8, p769-774. 6p.

Record details

Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States.

• Authors : Feldman, Steven R.¹ ; Rastogi, Shipra²; Lin, Jay³

• Source: Dermatology & Therapy. Sep2018, Vol. 8 Issue 3, p441-453. 13p.

Record details

Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.

• Authors : Feldman, Steven R.¹ (AUTHOR); Green, Lawrence² (AUTHOR); Kimball, Alexa B.³ (AUTHOR)

• Source: Journal of Dermatological Treatment. Dec2017, Vol. 28 Issue 8, p716-721. 6p.

Record details

Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.

• Authors : Feldman, Steven R.¹ (AUTHOR); Bushnell, Donald M.² (AUTHOR); Klekotka, Paul A.³ (AUTHOR)

• Source: Journal of Dermatological Treatment. Jun2016, Vol. 27 Issue 3, p224-227. 4p.

Record details

Real-world biologic and apremilast treatment patterns in patients with psoriasis and psoriatic arthritis.

• Authors : Feldman, Steven R.; Jingchuan Zhang; Martinez, Diane J.

Subjects: PSORIASIS treatment; PSORIATIC arthritis; BIOTHERAPY

• Source: Dermatology Online Journal; 2021, Vol. 27 Issue 9, p1-11, 11p

Record details

Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity Detection.

• Authors : Heron, Courtney E.; Ghamrawi, Rima I.; Balogh, Esther A.

Subjects: PSORIASIS treatment; BIOTHERAPY; IMMUNOASSAY

• Source: American Journal of Clinical Dermatology; Mar2021, Vol. 22 Issue 2, p221-231, 11p

Record details

The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.

• Authors : Langley, Richard G. B.¹ (AUTHOR) ; Feldman, Steven R.² (AUTHOR); Nyirady, Judit³ (AUTHOR)

• Source: Journal of Dermatological Treatment. Feb2015, Vol. 26 Issue 1, p23-31. 9p.

Record details

Assessing the utility of the decoy effect on biologic treatment preference.

• Authors : Bray, Jeremy K.; Feldman, Steven R.

Subjects: PSORIASIS treatment; PATIENT compliance; INJECTIONS

• Source: Dermatology Online Journal; 2021, Vol. 27 Issue 2, p1-4, 4p

Record details

Treatment Goals in Psoriasis: Which Outcomes Matter Most?

• Authors : Svoboda, Steven A.; Ghamrawi, Rima I.; Owusu, Dorellie A.

Subjects: PSORIASIS treatment; HEALTH outcome assessment; PSORIASIS

• Source: American Journal of Clinical Dermatology; Aug2020, Vol. 21 Issue 4, p505-511, 7p

Record details

Insight into psoriasis management: Commercial perspectives for the U.S. psoriasis market.

• Authors : Tran, Bryant¹ (AUTHOR); Feldman, Steven R.² (AUTHOR)

• Source: Journal of Dermatological Treatment. Feb2011, Vol. 22 Issue 1, p18-26. 9p. 2 Diagrams, 1 Graph.

Record details

Topical Clobetasol Propionate in the Treatment of Psoriasis.

• Authors : Feldman, Steven R.¹ ; Yentzer, Brad A.¹

• Source: American Journal of Clinical Dermatology. 2009, Vol. 10 Issue 6, p397-406. 10p. 1 Color Photograph, 1 Diagram, 1 Chart, 2 Graphs.

Record details

Patients’ Vehicle Preference for Corticosteroid Treatments of Scalp Psoriasis.

• Authors : Feldman, Steven R.¹; Housman, Tamara S.¹

• Source: American Journal of Clinical Dermatology. 2003, Vol. 4 Issue 4, p221-224. 4p.

Record details

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review.

• Authors : Murage, Mwangi J; Tongbram, Vanita; Feldman, Steven R

Subjects: RHEUMATOID arthritis; PATIENT compliance; PSORIASIS treatment

• Source: Patient Preference & Adherence; Aug2018, Vol. 12, p1483-1503, 21p

Record details

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab.

• Authors : Wechter, Todd; Cline, Abigail; Feldman, Steven R

Subjects: PSORIASIS treatment; THERAPEUTIC use of monoclonal antibodies; BIOTHERAPY

• Source: Therapeutics & Clinical Risk Management; Aug2018, Vol. 14, p1489-1497, 9p

Record details

The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis.

• Authors : Rajabi-Estarabadi, Ali; Hasanzadeh, Hournaz; Taheri, Arash

Subjects: DRUG efficacy; PSORIASIS treatment; DISEASES

• Source: Journal of Dermatological Treatment; Mar2018, Vol. 29 Issue 2, p111-115, 5p

Record details

Improving Management Strategies and Patient Adherence in the Treatment of Psoriasis.

• Authors : Feldman, Steven R.

Subjects: PSORIASIS treatment; BIOLOGICAL products; DRUGS

• Source: Journal of Managed Care Medicine; 2018, Vol. 21 Issue 1, p38-42, 5p, 1 Diagram, 1 Graph

Record details

Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review.

• Authors : Patel, Nupur U.; Felix, Kayla; Reimer, Danielle

Subjects: PSORIASIS treatment; THERAPEUTIC use of vitamin D; KERATINOCYTE differentiation

• Source: Clinical, Cosmetic & Investigational Dermatology; Sep2017, Vol. 10, p385-391, 7p

Record details

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.

• Authors : Papp, Kim A.; Bissonnette, Robert; Gooderham, Melinda

Subjects: PSORIASIS treatment; CLINICAL trials; OINTMENTS

• Source: BMC Dermatology; 10/3/2016, Vol. 16, p1-12, 12p

Record details

Review of maintenance of response to psoriasis treatments.

• Authors : Bartos, Simona; Hill, Dane; Feldman, Steven R.

Subjects: PSORIASIS treatment; RESPONSE rates; MAINTENANCE

• Source: Journal of Dermatological Treatment; Aug2016, Vol. 27 Issue 4, p293-297, 5p

Record details

Rethinking the costs of psoriasis management.

• Authors : Feldman, Steven R.¹ (AUTHOR)

• Source: Journal of Dermatological Treatment. Nov2017, Vol. 28 Issue 7, p573-573. 1p.

Record details

Implications of treatment resistant severe psoriasis for benchmarking quality of care.

• Authors : Feldman, Steven R.¹ (AUTHOR)

• Source: Journal of Dermatological Treatment. Sep2017, Vol. 28 Issue 6, p475-475. 1p.

Record details

Clinical potential of brodalumab in the management of psoriasis: the evidence to date.

• Authors : Sandoval, Laura F.; Williams, Brooke; Feldman, Steven R.

Subjects: PSORIASIS; PSORIASIS treatment; THERAPEUTIC use of monoclonal antibodies

• Source: Psoriasis: Targets & Therapy; 2015, Vol. 5, p35-40, 6p

Record details

Emerging treatment options for psoriasis.

• Authors : Taheri, Arash; Sandoval, Laura F.; Tuchayi, Sara Moradi

Subjects: MEDICAL emergencies; PSORIASIS treatment; INTERLEUKIN-17

• Source: Psoriasis: Targets & Therapy; 2014, Vol. 4, p27-35, 9p

Record details

Risankizumab for psoriasis.

• Authors : Cline, Abigail¹; Feldman, Steven R.^1,2,3

Subjects: *RESEARCH; PSORIASIS treatment; INTERLEUKINS

• Source: Lancet. 8/25/2018, Vol. 392 Issue 10148, p616-617. 2p. 1 Color Photograph.

Record details